A team has identified an experimental molecule capable of "reprogramming" the brain's immune cells to restore part of their ...

HAYA Therapeutics Announces First Cohort Dosed in Phase 1 Trial of HTX-001, an Investigational Cellular Reprogramming Therapy ...

Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men worldwide. However, the mechanisms controlling the early stages of prostate cancer ...

For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in. Peripheral vision fades first, so gradually that many people do not notice ...

Cancer cells rapidly adapt to treatments, developing resistance that makes chemotherapy less effective. Researchers used an existing anti-inflammatory drug to disrupt cancer cells’ ability to adapt by ...

By combining advanced cellular reprogramming with AI-driven protein design, the company aims to reverse biological ageing and tackle multiple diseases at once.

Retinal degeneration leads to irreversible vision loss and significantly impacts quality of life. Approximately 19.83 million Americans over the age of 40 are affected by age-related macular ...

Your smartphone can reverse aging photos with AI, but reversing cellular aging in living eyes just became reality. Life Biosciences’ experimental ER-100 therapy-the first treatment to literally ...